HomeCompareHOCPY vs JNJ

HOCPY vs JNJ: Dividend Comparison 2026

HOCPY yields 0.38% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HOCPY wins by $1.4K in total portfolio value
10 years
HOCPY
HOCPY
● Live price
0.38%
Share price
$171.28
Annual div
$0.65
5Y div CAGR
22.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$311.46
Full HOCPY calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — HOCPY vs JNJ

📍 HOCPY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHOCPYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HOCPY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HOCPY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HOCPY
Annual income on $10K today (after 15% tax)
$32.40/yr
After 10yr DRIP, annual income (after tax)
$264.74/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $438.87/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HOCPY + JNJ for your $10,000?

HOCPY: 50%JNJ: 50%
100% JNJ50/50100% HOCPY
Portfolio after 10yr
$20.7K
Annual income
$569.62/yr
Blended yield
2.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HOCPY
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
24.1
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HOCPY buys
1
JNJ buys
0
PoliticianChamberTickerTypeAmountDate
Daniel Goldman🏢 House$HOCPY▼ Sell$15,001 - $50,0002023-07-10
Daniel Goldman🏢 House$HOCPY▲ Buy$15,001 - $50,0002023-02-27
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHOCPYJNJ
Forward yield0.38%3.36%
Annual dividend / share$0.65$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR22.5%5.8%
Portfolio after 10y$21.4K$20.0K
Annual income after 10y$311.46$827.78
Total dividends collected$1.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: HOCPY vs JNJ ($10,000, DRIP)

YearHOCPY PortfolioHOCPY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,747$46.69$10,676$355.77+$71.00HOCPY
2$11,556$57.44$11,407$389.39+$149.00HOCPY
3$12,436$70.72$12,198$426.53+$238.00HOCPY
4$13,394$87.13$13,056$467.62+$338.00HOCPY
5$14,439$107.43$13,987$513.12+$452.00HOCPY
6$15,582$132.58$14,998$563.56+$584.00HOCPY
7$16,837$163.81$16,098$619.52+$739.00HOCPY
8$18,218$202.64$17,295$681.69+$923.00HOCPY
9$19,744$251.02$18,599$750.82+$1.1KHOCPY
10$21,438$311.46$20,022$827.78+$1.4KHOCPY

HOCPY vs JNJ: Complete Analysis 2026

HOCPYStock

HOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and medical related products, such as prosthetic ceramic fillers and metallic implants. It also operates Eyecity, a specialty retailer of contact lenses. In addition, the company provides information technology products, such as mask blanks and photomasks for manufacturing semiconductor chips; photomasks for liquid crystal display panels; glass disks for hard disk drives; and imaging products that include optical glasses/optical lenses, colored glass filters, and laser equipment/UV light resources. Further, it offers ReadSpeaker, a speech synthesis software; and cloud services comprising Kinnosuke that is a time and attendance management service, and Yonosuke, an electronic payslip service. HOYA Corporation was founded in 1941 and is headquartered in Tokyo, Japan.

Full HOCPY Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this HOCPY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HOCPY vs SCHDHOCPY vs JEPIHOCPY vs OHOCPY vs KOHOCPY vs MAINHOCPY vs ABBVHOCPY vs MRKHOCPY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.